Teacher Retirement System of Texas Buys 336,333 Shares of CVS Health Corporation $CVS

Teacher Retirement System of Texas boosted its position in shares of CVS Health Corporation (NYSE:CVS) by 97.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 682,987 shares of the pharmacy operator’s stock after purchasing an additional 336,333 shares during the period. Teacher Retirement System of Texas owned about 0.05% of CVS Health worth $51,490,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of CVS. Vanguard Group Inc. lifted its stake in CVS Health by 1.7% in the 2nd quarter. Vanguard Group Inc. now owns 120,399,131 shares of the pharmacy operator’s stock valued at $8,305,132,000 after acquiring an additional 2,063,737 shares in the last quarter. State Street Corp raised its holdings in shares of CVS Health by 1.4% in the second quarter. State Street Corp now owns 58,788,585 shares of the pharmacy operator’s stock valued at $4,055,237,000 after purchasing an additional 800,414 shares during the last quarter. Geode Capital Management LLC boosted its holdings in CVS Health by 2.4% during the second quarter. Geode Capital Management LLC now owns 28,635,233 shares of the pharmacy operator’s stock worth $1,966,083,000 after purchasing an additional 675,824 shares during the last quarter. Invesco Ltd. increased its stake in CVS Health by 15.3% in the 2nd quarter. Invesco Ltd. now owns 23,532,479 shares of the pharmacy operator’s stock valued at $1,623,270,000 after buying an additional 3,118,626 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of CVS Health during the 2nd quarter worth about $1,358,698,000. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health News Summary

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Large bullish options activity: Unusually heavy call buying — about 37,560 calls in a single session (roughly +59% vs. average) — signals short?term investor optimism and could support upward price momentum. Investors Buy Large Volume of CVS Health Call Options (NYSE:CVS)
• Positive Sentiment: Operational changes to ease utilization and share savings: CVS announced cuts to prior authorizations and an expansion of rebate?sharing—moves that can reduce friction for providers and patients and potentially improve script flow and client relationships. CVS Health cuts prior authorizations, expands rebate sharing
• Positive Sentiment: Business growth and innovation initiatives: Announcements on making health insurance “simpler and more affordable” and a university partnership for AI and pharmacy workforce development support long?term growth and cost efficiency narratives. CVS Health® makes health insurance simpler and more affordable for Americans CVS Health, U of Maryland partner on AI, pharmacy workforce growth
• Neutral Sentiment: Legal developments mixed: Bloomberg Law reports CVS and UnitedHealth successfully fended off a specific antitrust lawsuit over drug costs — a legal win that reduces near?term tail risk but does not eliminate broader regulatory scrutiny. UnitedHealth, CVS Fend Off Antitrust Lawsuit Over Drug Costs
• Negative Sentiment: Congressional antitrust findings and sustained PBM scrutiny: A House Judiciary Committee report and related coverage accuse CVS/Caremark of impeding competition and targeting independent pharmacies; lawmakers have flagged potential antitrust violations and executives were grilled in hearings—this political and regulatory pressure raises the risk of fines, remedies, or changes to PBM practices that could hurt margins. House Judiciary Committee Report Accuses CVS Health of Thwarting Competition and Targeting Independent Pharmacies House committee accuses CVS of impeding pharmacy competition CVS faces antitrust scrutiny over PBM practices

Wall Street Analyst Weigh In

Several analysts recently issued reports on CVS shares. Mizuho upped their target price on CVS Health from $88.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, December 10th. Wall Street Zen downgraded CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Raymond James Financial boosted their target price on shares of CVS Health from $75.00 to $90.00 in a report on Friday, October 31st. Piper Sandler reaffirmed an “overweight” rating and set a $101.00 price target (up from $99.00) on shares of CVS Health in a research report on Wednesday, December 10th. Finally, Leerink Partners boosted their price objective on shares of CVS Health from $86.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, October 16th. Nineteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $94.86.

CVS Health Stock Performance

Shares of CVS stock opened at $82.65 on Friday. The company has a market capitalization of $104.92 billion, a price-to-earnings ratio of 217.51, a PEG ratio of 0.75 and a beta of 0.48. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.63 and a current ratio of 0.83. CVS Health Corporation has a 52 week low of $52.69 and a 52 week high of $85.15. The company has a 50-day simple moving average of $78.95 and a 200 day simple moving average of $74.62.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. The company had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business’s revenue was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, sell-side analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, February 2nd. Investors of record on Thursday, January 22nd will be paid a $0.665 dividend. The ex-dividend date is Thursday, January 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.2%. CVS Health’s dividend payout ratio is 700.00%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.